Oral Answers to Questions

Andrea Jenkyns Excerpts

Tuesday 7th February 2017 Commons Chamber

[Nicola Blackwood]

We are working hard on that exact point.

[Andrea Jenkyns (Morley and Outwood) (Con)]

20. As the Health Secretary is aware, my constituent Abi Longfellow is suffering with a rare kidney condition—dense deposit disease. What plans do the Government have to increase access to specialist drugs for those such as Abi with ultra-rare diseases?

[Nicola Blackwood]

The National Institute for Health and Care Excellence and NHS England are working together to better manage access to new drugs and medical technologies for rare diseases. We are also working on the UK strategy for rare diseases and its implementation. It has 51 commitments to be implemented by 2020 to improve the lives of constituents such as my hon. Friend’s.

NHS and Social Care Funding

Andrea Jenkyns Excerpts

Wednesday 11th January 2017 Commons Chamber

[Andrea Jenkyns (Morley and Outwood) (Con)]

I begin by objecting to the exaggerated language used over the weekend by Mike Adamson, the chief executive of the British Red Cross. What he said does a huge disservice to our hard-working healthcare professionals in the NHS. Such language was ill-thought-out, sloppy and irresponsible. The Red Cross does some fantastic work, as I am sure both sides of the House agree, but as a registered charity it is legally obliged to be apolitical. If Mike Adamson cannot remain neutral, I suggest that he examines his position carefully.

As a member of the Health Committee and chair and co-founder of the patient safety all-party group, healthcare is extremely important to me, and I am proud to be a Conservative Member of Parliament under this Government. It is thanks to this Government and this Health Secretary that NHS funding is at record levels.

The Government are committed to delivering a seven-day NHS and to expanding access to GP surgeries and hospital-based consultants at evenings and weekends. This winter, the NHS has made more extensive preparations than ever before. As the Secretary of State mentioned earlier, in the run-up to the winter period, there were over 1,600 more doctors and 3,000 more nurses than just a year ago. That is a record of which to be proud, and it would not have been achieved had we had the Opposition party running our national health service.

As chair of the patient safety APPG, I am pleased to say that the Government have introduced a new Ofsted-style inspection regime for the Care Quality Commission to improve patient safety. Hospital infections have been halved since 2010, with the level of MRSA down by virtually 50% and clostridium difficile by more than 50%. It is this Health Secretary who has taken the lead on this issue and put patients at the heart of the NHS.

Record numbers of people are being treated in our NHS and there are pressures on the service, but it is not this Conservative Government who are a threat to the NHS. If we look at the appalling situation of the NHS in Labour-controlled Wales, we will see that funding is being cut. As the latest statistics show, the NHS in Wales is failing to meet the four-hour A&E targets by a wide margin. It is clear to see who is rarely the defender of our national health service and who would cut investment.

In conclusion, it is this Government who are increasing spending on our NHS, who are focusing on improving patient safety and who are dedicated to providing the best possible service.

Mental Health and NHS Performance

Andrea Jenkyns Excerpts

Monday 9th January 2017 Commons Chamber

[Mr Speaker]

In wishing the hon. Members for Morley and Outwood and for Filton and Bradley Stoke all the best in the weeks and months ahead, I call Andrea Jenkyns.

[Andrea Jenkyns (Morley and Outwood) (Con)]

Thank you, Mr Speaker. First, I echo some of the points made by the Secretary of State regarding mental health support for expectant mothers. As one myself, I have to say that the midwives have been fantastic. Right from the very first appointments at grassroots level, they mention mental health, so we are feeling the support on the ground.

I welcome today’s statement, which shows the Government’s commitment to mental health by making it a centrepiece of the agenda. One in 50 young people in Yorkshire receive care for mental health. How will the new approach address the concerns of the young people and their parents, and what measures are in place to reduce the waiting list for child and adolescent mental health services?

[Mr Hunt]

I add to Mr Speaker’s comments my very good wishes and confidence that my hon. Friend the Member for Morley and Outwood (Andrea Jenkyns) will get superb care from the NHS. I thank her for campaigning on patient safety. I am sure she will be pleased to hear that our principal safety campaign this year is on maternity safety.

In bald numbers, the plan will mean that we will treat 1 million more people with mental health conditions a year by the end of this Parliament. Of course, many of those will be in Yorkshire. An additional 70,000 young people will get treatment every single year and I hope that will bring down the CAMHS waiting times. We also want to do work in schools to prevent people from getting on the CAMHS waiting list in the first place.

CQC: NHS Deaths Review

Andrea Jenkyns Excerpts

Tuesday 13th December 2016 Commons Chamber

[Mr Hunt]

I thank the shadow Health Secretary for the constructive nature of his comments. He is absolutely right in that, because this issue can unite people in all parts of the House. In fairness, these tragedies happen when those on either side of the House are responsible for the NHS, and we all have a responsibility to work to do better than we are doing at the moment.

I particularly agree with the hon. Gentleman that front-line doctors and nurses work incredibly hard, and we need to get away from a blame culture when these tragedies happen. That blame culture is the root cause of why we are not learning as we should from the problems that arise, because people are worried about what will happen to them personally if they speak out. We have seen this with a number of tragedies. Through the national framework, we are trying to move away from a blame culture. Of course people have to be held accountable. If there is gross negligence and people do totally irresponsible things, then there must be no hiding place and proper accountability: that is what families rightly insist on. For the vast majority of the time, however, people are just trying to do their jobs as best they can. As he rightly says, it is often a systemic problem that can be solved with systemic changes. We are now trying to implement the culture of investigation that has worked so successfully in the airline industry and other industries.

I absolutely assure the hon. Gentleman that families and carers will be equal partners as we develop the new national guidance. This area was one of the most shocking things about the CQC report. I am sure that it was a great surprise to many people in the NHS how excluded many families felt. We clearly have to do better in that respect.

The hon. Gentleman talked about the National Patient Safety Agency, and I pay credit to Sir Liam Donaldson, who was chief medical officer under the previous Labour Government and a great champion of patient safety, but we now have different structures in place. The new CQC inspection regime and the healthcare safety investigation branch are giving equal, if not greater, priority to patient safety.

We discuss on many occasions the funding issues that the hon. Gentleman raised, as I think he is acknowledging with his facial expressions. The point I would make, because we have had a good exchange and I do not want to get into the specific politics of NHS funding, is that this is a win-win, because avoidable harm and death is incredibly expensive for the NHS. The time it takes to carry out investigations when things go wrong is utterly exhausting for the doctors, nurses and managers involved, who would much rather be doing front-line care. Preventing these things from happening in future is the best possible way of freeing up time for people on the frontline.

I will take away what the hon. Gentleman said about the Elizabeth Dixon case and find out what is happening with that review.

The real lesson of today is that every family, every doctor and every nurse has a simple aim when a tragedy happens. It is not about money; it is about making sure that lessons are learned openly and transparently so that history does not repeat itself. That is really what this is about, and that is why we will continue our mission to make NHS care the safest and highest quality in the world.

[Andrea Jenkyns (Morley and Outwood) (Con)]

The Secretary of State has answered my point, but I would like to say, as chair of the all-party parliamentary group on patient safety, that the publication of avoidable death figures is really welcome news. I support what he said about creating a just culture where clinicians and other staff feel safe. That is important so that they can speak up about failure, and vital in delivering the high-quality but, most importantly, safer and better-value services the NHS aspires to.

[Mr Hunt]

I thank my hon. Friend, who does a huge amount of work on patient safety, not least because of sadness in her own family’s experiences that gives her particular passion in this respect. This is absolutely about creating a just culture. Inspiring people like James Titcombe, who lost his own son at Morecambe Bay, talk far more eloquently than I can about the need to get this right. Part of that just culture is about justice for people who use the NHS in future, to whom we have a responsibility to learn the lessons and make sure that mistakes are not repeated. One of the really important things we need to get right is to make sure that when something goes wrong in one place, there is a national way in which the lessons can be conveyed right across the NHS as quickly as possible.

NHS Spending

Andrea Jenkyns Excerpts

Wednesday 6th July 2016 Commons Chamber

[Dr Whitford]

I totally agree. Of course, we all want the NHS to have more money. It is the United Kingdom’s single most prized possession and creation. The problem is that we did not counter the argument that it was struggling because people from the EU were taking up the appointments and the beds. EU nationals are much more likely to be looking after us than to be standing in front of us in the queue. There is an absolute responsibility on us all, particularly on the missing members of the leave campaign. This is very much a case of a big boy doing it and running away—very, very quickly.

[Andrea Jenkyns (Morley and Outwood) (Con)]

As somebody who was in the leave campaign, I think it is important that we remember that we worked across parties on it, whichever side we were on. In Yorkshire, I worked with colleagues from the Green party, the Labour party and UKIP, although I did not work with the SNP, obviously. It is the responsibility of both camps. I have seen “Project Fear” in both camps.

We need to move on from this now. It is pure economics. If we are pulling out of the EU, as the public have voted to do and as I am personally happy that we are doing, we must make sure that we start talking Britain up; otherwise we will talk ourselves into a recession. Members on both sides of the House need to pull together and talk Britain up. At the end of the day, both sides could have handled this better.

[Madam Deputy Speaker (Mrs Eleanor Laing)]

Order. Before the hon. Member for Central Ayrshire (Dr Whitford) answers the intervention, I must remind the House that this debate is not about the EU campaign. We are talking specifically about the NHS. I understand that the hon. Lady was—perfectly reasonably—using examples, but we must not stray any further.

--- Later in debate ---

[Joan Ryan (Enfield North) (Lab)]

I am pleased to follow the hon. Member for Central Ayrshire (Dr Whitford) and agree with many of her points.

I share concerns expressed about the misleading statements made on the national health service during the EU referendum campaign. Many of my constituents who voted to leave were swayed by the pledge that a future outside the European Union could result in £350 million extra every week being invested in our NHS—and if not £350 million, then £120 million would do very nicely at the moment and make a big difference. Whether they voted leave or remain, people feel very disillusioned with such misleading statements.

The breathtaking speed with which prominent figures from the leave campaign have backtracked on that promise shows how hollow their words really were. People on both sides of the debate are upset and angry about what has happened. They understand that our hospitals, doctors and nurses need better support and more investment. I therefore fully support the motion.

[Andrea Jenkyns]

I completely agree with the right hon. Lady that we need more investment, but does she agree that the Government are right to point out that we have invested an extra £8 billion in the NHS already?

[Joan Ryan]

If the hon. Lady looks at my constituency she will see a perfect storm when it comes to health funding. We are underfunded in public health, in social care, in primary care and in acute care. She can come up with whatever figure she likes, but the experience on the ground is that we are suffering very badly.

I will come on to talk about the Care Quality Commission report, out today, on our hospital. I do not know whether the hon. Lady has seen it, but if she wants to talk about increased spending, I suggest she look at that report. What it says about what is going on in an acute care hospital is unprecedented.

Junior Doctors Contract

Andrea Jenkyns Excerpts

Wednesday 6th July 2016 Commons Chamber

[Mr Hunt]

I am happy to give that assurance. One of the most exciting things in the NHS, despite a lot of the doom and gloom in the headlines, is that we are seeing a transformation in safety culture. Even though we are now doing about 4,500 more operations every day, the proportion of patients being harmed is down by about a third in just three years. I think there is a transformation, but of course there is a lot more to do, as I am no doubt going to hear.

[Andrea Jenkyns (Morley and Outwood) (Con)]

I am shocked that we are here yet again. If we look at the history, 90% of the contract has been renegotiated. There have been years of negotiations. This contract is far safer for patients. Regardless of what the Opposition say, it cannot be laid at the Secretary of State’s door if the junior doctors decide to take strike action. We should stop using patients as pawns and put patients first. I would like to thank the Secretary of State for his perseverance. Does he agree that, through its relentless pursuit of partisan politics, the BMA has backed itself into a corner and put patients at risk?

[Mr Hunt]

The way patients have suffered—there have been over 20,000 cancelled operations during this process—has been very disappointing. My hon. Friend is absolutely right to campaign on issues of hygiene and cleanliness, which lead to so many tragedies when they are not properly attended to. I hope we can move on now. I do believe that, despite the disappointing rejection of this deal in the ballot, some trust has been established between the leaders of the BMA and the Government, and we have had a productive dialogue. We have made a number of changes to the May contract since announcing it—things that they suggested and that we agreed to. I would like to continue that process and build that trust.

Oral Answers to Questions

Andrea Jenkyns Excerpts

Tuesday 5th July 2016 Commons Chamber

The Secretary of State was asked—

[Andrea Jenkyns (Morley and Outwood) (Con)]

1. What plans the Government have to lead the international response to the recommendations of the final report of the Review on Antimicrobial Resistance, published in May 2016.

[Maggie Throup (Erewash) (Con)]

16. What plans the Government have to lead the international response to the recommendations of the final report of the Review on Antimicrobial Resistance, published in May 2016.

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

The O’Neill AMR review is galvanising global awareness, as I have seen for myself, and it is greatly to the Prime Minister’s credit that he showed the foresight to commission it. The UK continues to play a global leadership role on antimicrobial resistance. We co-sponsored the World Health Organisation’s 2015 global action plan on AMR, we created the Fleming fund to help poorer countries to tackle drug resistance, and we are now championing action, including taking forward the O’Neill review’s recommendations, through the United Nations, the G7, and the G20.

[Andrea Jenkyns]

I recently met biotech firm Matoke Holdings, which has developed a new technology—reactive oxygen technology. It has found that this technology forms the basis of a whole new generation of antibiotics that has been proven to combat multi-resistant bacteria, including MRSA. This is an incredibly exciting development. Will my hon. Friend and her team agree to meet Matoke Holdings to hear about the new technology and the pace at which it has developed? What are the Government doing to support research into new antibiotics?

[Jane Ellison]

My hon. Friend will be aware that a key focus of the O’Neill review was how to incentivise the development of new antimicrobials. It is scary to think that there has not been a new class of antibiotics for some decades now. The Government are funding an extensive AMR research programme. Matoke Holdings has been in contact with the Department, and we are in the process of arranging a meeting to discuss reactive oxygen technology in the coming weeks. My ministerial colleague the Under-Secretary of State for Life Sciences has indicated that he would also be happy to have such a meeting.

--- Later in debate ---

[Jane Ellison]

As Members will know, the Department has asked the Advisory Committee on the Safety of Blood, Tissues and Organs—SaBTO—to review the donor selection criteria for blood donation that relate to men who have sex with men. SaBTO has approved the remit, the terms of reference and the work streams, and it is cracking on. It has a second meeting coming up later this month. The chair of the working group has written to the chair of the all-party group, welcoming its inquiry and inviting it to contribute evidence during the autumn.

[Andrea Jenkyns (Morley and Outwood) (Con)]

T7. To expand on the question asked by the shadow Secretary of State, I too would like to raise the case of my constituent Abi Longfellow who suffers from dense deposit disease and is awaiting a decision by the NHS’s specialised commissioning body. She and her family have been subjected to frequent delays and miscommunications. I first met Health Ministers, NICE and NHS England a year ago to discuss Abi’s situation. What steps will the Government take to ensure that decisions on treatments such as this are taken in a timely fashion and that families are kept updated on the progress of those decisions?

[The Parliamentary Under-Secretary of State for Life Sciences (George Freeman)]

My hon. Friend raises an important point. NHS England is currently unable to take final decisions on this year’s new treatments, including this particular drug, until the courts have decided whether pre-exposure prophylaxis HIV prevention should compete with other candidate drugs. She makes an important point about timeliness, and that is why I am leading an accelerated access review to speed up the way in which such decisions are taken.

Junior Doctors Contracts

Andrea Jenkyns Excerpts

Monday 25th April 2016 Commons Chamber

[Mr Hunt]

I have to say that the right hon. Gentleman never whispered sweet nothings in my ear, and he certainly has not done so since being in opposition. With regard to doing what it takes, let me tell the hon. Gentleman directly that we have been trying to solve this problem for three years, with 75 meetings, 74 concessions and three independent processes. We have been doing everything we possibly can to solve this problem. What we have is a very intransigent and difficult junior doctors committee of the BMA, which has refused to negotiate sensibly. In that situation, the Health Secretary has a simple choice: to move forward or to give up. When it comes to patient safety, we are moving forward.

[Andrea Jenkyns (Morley and Outwood) (Con)]

Patient safety is a matter close to my heart. Tomorrow, doctors will shout that this strike is not about pay or Saturday working, but about patient safety. They will march under banners declaring the contract to be unsafe and unfair. Will the Secretary of State reassure the House that there is absolutely no prospect of the Government giving into this naked attempt by the doctors’ union to hold vulnerable patients as hostage in a row over pay? Patients must always come first.

[Mr Hunt]

My hon. Friend is absolutely right. The truth is that being Health Secretary is never easy, whichever Government they are in, but where they have made mistakes in the past is where they have been too willing to compromise on vital issues of patient safety, and a seven-day NHS is one of those issues. When it comes to safety, Channel 4’s “FactCheck”, which is not a known supporter of the Government, has compared the new contract with the old one and said that, on the face of it, the new one is safer. That should reassure many doctors that this is the right thing for the NHS to do, and they should work with us, not against us.

Junior Doctors Contracts

Andrea Jenkyns Excerpts

Monday 18th April 2016 Commons Chamber

[Mr Hunt]

I am very happy to do so. We are introducing a new contract from this August, and it will be for all junior doctors. It will go progressively through the different ranks of junior doctors and, over the course of the next year, the vast majority of new doctors will move on to the new contracts. The reason that we did not use the word “impose” in the original statement was not a matter of semantics. We are proceeding with this new contract and everyone will move on to it, which is the gist of what most people mean by this. What we are not doing is changing existing contracts, so when people move trust or move to a new position, they will move on to a new contract. That is why we have used the term “introduction” of new contracts. However, it would have been much better if the introduction of the new contracts had been done through a negotiated process. That is why we took such trouble: we went to 75 meetings and made 73 different concessions in order to try to do this on a negotiated basis. Very regrettably, that proved not to be possible, which is why we took the difficult decision to proceed with these new contracts anyway.

[Andrea Jenkyns (Morley and Outwood) (Con)]

Does the Secretary of State agree that it is totally unjustified for doctors to demand higher premium rates at weekends when almost all other NHS workers, and indeed most other working people across the economy, do not get them? It is completely disrespectful for the BMA to suggest that doctors’ lives are somehow uniquely disproportionately inconvenienced by Saturday shifts and that those of other people are not.

[Mr Hunt]

It is true that the BMA rejected Saturday premium pay that was more generous than the Saturday premium pay offered to nurses, healthcare assistants or paramedics working in the same hospitals and operating theatres as those doctors. Many people will ask whether that was a reasonable position to take, given that the doctors’ overall pay was protected. I think they will also ask whether, even if the doctors disagreed with the Government on that point, it was appropriate or proportionate for them to withdraw life-saving emergency care from patients in the pursuance of their disagreement. I wonder whether that is something that will shape many people’s confidence in what the NHS stands for.

Contaminated Blood

Andrea Jenkyns Excerpts

Tuesday 12th April 2016 Commons Chamber

[Dr Monaghan]

I absolutely agree with my hon. Friend. It is a tragic case that he outlines, and I will come to his specific point shortly.

On 21 January 2016, the Health Minister stated that the UK Government wanted to increase the amount of money on offer for victims of infected blood by £100 million, in addition to the £25 million announced in March 2015 by the Prime Minister. This takes the total to £225 million over the five years to 2020. As we know, there is a 12-week consultation on these proposals that closes this week, on 15 April. However, the proposed payment schemes have been heavily criticised by many of those affected for being outdated and confused in structure. That is my experience of them too. They also appear unfair.

The UK Government have estimated that the Department will spend a further £570 million over the projected lifetime of the reformed scheme, but analysis shows that the Department wants to cap annual payments for victims in England at £15,000 and that these will no longer be index linked and so will not increase with the cost of living. The UK Government also want to remove regular discretionary payments, including the winter fuel allowance and the £1,200 per child annual payment.

[Andrea Jenkyns (Morley and Outwood) (Con)]

On the point about the cost of living, I have several constituents in the same situation. One suggested that pension payments be increased to at least the level of the living wage. What does the hon. Gentleman think of that idea?

[Dr Monaghan]

I would absolutely support that suggestion. I would also note that many victims in England now face cuts of up to £7,000 a year, together with cumulative losses from the freezing of six annual payments to patients of £15,000 a year, time-limited support for partners and spouses after patients’ deaths, and the ending of help for the children and parents of those affected. Moreover, victims will no longer have access to grants for support with such things as mobility issues and modifications to property; nor will they have access to free expert advice.

The Haemophilia Society, which campaigns on behalf of victims of this scandal, has said that it has deep concerns about the proposals for England. It compared the proposals for England to those in Scotland, saying:

“These concerns are compounded by the fact that similar proposals in Scotland offer more generous payments to its affected community. There is a risk that, if both sets of proposals are accepted (as they currently stand), affected people in England will receive much lower incomes that those in Scotland.”

The Scottish Government have already provided £32 million over the last 10 years to the current UK-wide schemes, so they are already committed to support those infected in Scotland. Nevertheless, on 18 March this year, the Scottish Government announced a substantial package of increased financial support for those affected by infected NHS blood and blood products in Scotland, amounting to an additional £20 million over the next three years alone. The new Scottish scheme will see annual payments for those with HIV and advanced hep C nearly double from £15,000 to £27,000 a year, and those affected with both HIV and hep C will have their annual payments increase from £30,000 to £37,000.